These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 15763191)

  • 21. [Clinical therapeutic efficiency of chemoreduction and local therapy for children with retinoblastoma].
    Qian J; Xue K; Gao YJ; Yuan YF; Shan HD; Bi YW
    Zhonghua Yan Ke Za Zhi; 2010 Apr; 46(4):312-6. PubMed ID: 20654057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Results of combined chemotherapy and local ophtalmic therapy for intraocular retinoblastoma].
    Balwierz W; Pietrys D; Romanowska-Dixon B; Kobylarz J; Pawińska-Wasikowska K; Moryl-Bujakowska A
    Przegl Lek; 2010; 67(6):404-8. PubMed ID: 21344770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma.
    Shields CL; Honavar SG; Shields JA; Demirci H; Meadows AT; Naduvilath TJ
    Arch Ophthalmol; 2002 Apr; 120(4):460-4. PubMed ID: 11934319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A retrospective review of hearing in children with retinoblastoma treated with carboplatin-based chemotherapy.
    Lambert MP; Shields C; Meadows AT
    Pediatr Blood Cancer; 2008 Feb; 50(2):223-6. PubMed ID: 17278120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemoreduction for retinoblastoma: analysis of tumor control and risks for recurrence in 457 tumors.
    Shields CL; Mashayekhi A; Cater J; Shelil A; Meadows AT; Shields JA
    Trans Am Ophthalmol Soc; 2004; 102():35-44; discussion 44-5. PubMed ID: 15747743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective ophthalmic arterial infusion of chemotherapeutic drugs for recurrent retinoblastoma.
    Trinavarat A; Chiewvit P; Buaboonnam J; Sanpakit K; Atchaneeyasakul LO
    J Pediatr Hematol Oncol; 2012 Aug; 34(6):e218-21. PubMed ID: 22584782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multifaceted chemotherapy for trilateral retinoblastoma.
    Dimaras H; Héon E; Doyle J; Strahlendorf C; Paton KE; Halliday W; Babyn P; Gallie BL; Chan HS
    Arch Ophthalmol; 2011 Mar; 129(3):362-5. PubMed ID: 21402997
    [No Abstract]   [Full Text] [Related]  

  • 28. Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes.
    Shields CL; Ramasubramanian A; Thangappan A; Hartzell K; Leahey A; Meadows AT; Shields JA
    Ophthalmology; 2009 Mar; 116(3):544-551.e1. PubMed ID: 19157557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of overt extraocular retinoblastoma.
    Chantada G; Fandiño A; Casak S; Manzitti J; Raslawski E; Schvartzman E
    Med Pediatr Oncol; 2003 Mar; 40(3):158-61. PubMed ID: 12518344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Results of combined chemotherapy and local ophtalmic therapy of children with intraocular retinoblastoma].
    Balwierz W; Kobylarz J; Starzycka M; Dluzniewska A
    Med Wieku Rozwoj; 2001; 5(3 Suppl 1):15-23. PubMed ID: 12004148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overview: chemotherapy for retinoblastoma: an expanding area of clinical research.
    Schouten-Van Meeteren AY; Moll AC; Imhof SM; Veerman AJ
    Med Pediatr Oncol; 2002 Jun; 38(6):428-38. PubMed ID: 11984806
    [No Abstract]   [Full Text] [Related]  

  • 32. Chemoreduction in the management of retinoblastoma.
    Shields JA; Shields CL; Meadows AT
    Am J Ophthalmol; 2005 Sep; 140(3):505-6. PubMed ID: 16139001
    [No Abstract]   [Full Text] [Related]  

  • 33. Retinocytoma shows lack of response to chemoreduction.
    Chung J; Turaka K; Shields CL
    J Pediatr Ophthalmol Strabismus; 2010 Dec; 47 Online():e1-3. PubMed ID: 21175116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Retinoblastoma update--therapy (Part II)].
    Pogrzebielski A; Shields CL; Romanowska-Dixon B; Shields JA
    Klin Oczna; 2006; 108(4-6):258-62. PubMed ID: 17020008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment modalities and results of comprehensive therapy for extended retinoblastoma in children].
    Belkina BM; Durnov LA; Poliakov VG; Goldobenko GV; Glekov IV; Ushakova TL
    Vopr Onkol; 1997; 43(4):435-9. PubMed ID: 9381699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical manifestations and treatment of retinoblastoma in Korea.
    Chung SE; Sa HS; Koo HH; Yoo KH; Sung KW; Ham DI
    Br J Ophthalmol; 2008 Sep; 92(9):1180-4. PubMed ID: 18650212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subconjunctival carboplatin in fibrin sealant in the treatment of transgenic murine retinoblastoma.
    Van Quill KR; Dioguardi PK; Tong CT; Gilbert JA; Aaberg TM; Grossniklaus HE; Edelhauser HF; O'Brien JM
    Ophthalmology; 2005 Jun; 112(6):1151-8. PubMed ID: 15885791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retinoma underlying retinoblastoma revealed after tumor response to 1 cycle of chemotherapy.
    Dimaras H; Khetan V; Halliday W; Héon E; Chan HS; Gallie BL
    Arch Ophthalmol; 2009 Aug; 127(8):1066-8. PubMed ID: 19667353
    [No Abstract]   [Full Text] [Related]  

  • 39. Orbital fibrosis and intraocular recurrence of retinoblastoma following periocular carboplatin.
    Kim JW; Yau JW; Moshfeghi D; Fishman M
    J Pediatr Ophthalmol Strabismus; 2010 May; 47 Online():e1-4. PubMed ID: 21214147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Iontophoretic delivery of carboplatin in a murine model of retinoblastoma.
    Hayden B; Jockovich ME; Murray TG; Kralinger MT; Voigt M; Hernandez E; Feuer W; Parel JM
    Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3717-21. PubMed ID: 16936078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.